A SIMPLE KEY FOR ABBV-744 BRD4 INHIBITION IN CANCER CELL LINES UNVEILED

In Phase A, individuals will receive distinctive doses and schedules of oral ABBV-744 pill to recognize Protected dosing regimen. Supplemental members is going to be enrolled at the determined monotherapy dosign regimen. In Phase B, individuals will receive oral ruxolitinib and ABBV-744 are going to be supplied as "incorporate-on" therapy. In Phase